A comparative analysis of quality management standards for contract research organisations in clinical trials

International Journal of Health Care Quality Assurance

Volumn 20, Issue 1, 2007, Pages 16-33

  Murray, Elizabeth ^a   McAdam, Rodney ^b  

^a Bio Kinetic Europe Ltd   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Best practice; Northern Ireland; Pharmaceuticals industry; Product trials; Quality management; Standards

Indexed keywords

ARTICLE; CLINICAL TRIAL; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HUMAN; INTERNATIONAL COOPERATION; MANAGEMENT; ORGANIZATION AND MANAGEMENT; STANDARD; TOTAL QUALITY MANAGEMENT;

CLINICAL TRIALS AS TOPIC; CONTRACT SERVICES; DRUG INDUSTRY; HUMANS; INTERNATIONAL COOPERATION; MANAGEMENT AUDIT; TOTAL QUALITY MANAGEMENT;

EID: 33846510017     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526860710721196     Document Type: Article

References (19)

1. Baxendale, R. (2004), "Revolution in quality management", Quasar - Quality Assurance and Research, No. 87, p. 5.
2. Cheetham, B. (compiler) (2005), "Revision of the ENGAGE Auditing Guideline: an optional guideline for good clinical practice compliance and quality management systems auditing", International Journal of Pharmaceutical Medicine, Vol. 19, pp. 89-96 (prepared by the Audit Working Party of the EFGCP).
3. EMEA (1995), ICH Topic E6: Note for Guidance on Good Clinical Practice, CPMB/ICH/135/95, EMEA, London.
4. EMEA (2004), "The European Medicines Agency integrated quality management system", EMEA/MB/034/04, available at: www.emea.eu.int/pdfs/ general/direct/qms/ 003404 en.pdf.
5. European Commission (2005a), 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the Approximation of the Laws, Regulations and Administration Provisions of the Member States Relating to the Implementation of Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use (Article 1 Scope 3), European Commission, Brussels.
6. European Commission (2005b), 2005/28/EC: Laying Down Principles and Detailed Guidelines for Good Clinical Practice as Regards Investigational Medicinal Products for Human Use, as Well as the Requirements for Authorisation of the Manufacturing or Importation of Such Products (Preamble, 8), European Commission, Brussels.
7. European Network of GCP Auditors and other GCP Experts (ENGAGE) (1997), Optional Guideline for Good Clinical Practice Compliance and Quality Systems Auditing, ENGAGE, Brussels, 21 August.
8. Gittelson, P.L. (1996), "A systems audit approach to non-standard systems in clinical research", Drug Information Journal, Vol. 30, pp. 703-8.
9. GMP (2004), EC Guide to GMP, GMP, London, Ch. 1.
10. HMSO (1999), SI 1306/1999 Interpretation 1, SI standard publication, HMSO, London.
11. ISO (2000), "9001:2000 and FDA quality system", available at: www.fda.gov/cdrh/ devadvice/ ISO9001.pdf.
12. ISO (2002), ISO 19011:2002. Guidelines for Quality and/or Environmental Management Systems Auditing, ISO, Geneva, available at: www.iso.ch.
13. Oakland, J.S. (2004), Oakland on Quality Management, Elsevier Butterworth-Heinemann, Oxford.
14. Russell, M. (2004), "Understanding the role of the QP in clinical trials, David Begg Associates", paper presented at the MHRA Breakfast Forum on QP Transitional Arrangements, BMA House, London, 21 September.
15. Schnurr, B., Alzer, M. and Harrison, F. (2005), "Setting the standard", Good Clinical Practice Journal, Vol. 12 No. 5, pp. 29-31.
16. Sweeney, F. (1994), "Merging GCP and ISO 9000 requirements - a source of synergy in quality management of clinical research", Drug Information Journal, Vol. 28, pp. 1097-104.
17. Tielemans, D. (2004), "How to implement ISO 9001 in a GCP/CRO environment", European Pharmaceutical Contractor, Summer, pp. 46-50, available at: www.inpharm.com/static/intelligence/pdf/MAG_243424.pdf.
18. US Department of Health and Human Services, Food and Drug Administration (FDA) (1999), "Managing the risks from medical product use - creating a risk management framework. Part 2 - is the FDA maintaining the quality of its pre-marketing review?", report to the FDA Commissioner from the Task Force on Risk Management, available at: www.fda.gov/oc/tfrm/Part2.html.
19. Visschedijk-Brinkman, M. (2004), "How to set up and manage QC and QA" paper presented at the BARQA 2004 Annual Conference - Compliance and Quality, Crowne Plaza, Liverpool, 10-12 November.